AR and NAR are diseases associated to anxiety and depression, at least in women.

No abstract

Objective To assess whether loss of energy and concentration difficulty are related to allergic rhinitis. Design A cross-sectional study. Setting Secondary care allergy outpatients. Participants A total of 100 patients with allergic rhinitis and 96 healthy subjects. Main Outcome Measure: Loss of energy and concentration difficulty were assessed through a survey using the Beck Depression Inventory-II (BDI-II). Results The average BDI-II score was higher in the allergic rhinitis population than in the healthy controls (12.8 points vs 1.8 points, P < .0001), and the frequencies of loss of energy (69.0% vs 32.3%) and concentration difficulty (65.0% vs 34.4%) were higher in patients with allergic rhinitis ( P < .0001). The prevalence of depression was 0% in the control group and 38% in the case group ( P < .0001). Allergic rhinitis and depression were independently associated with loss of energy, odds ratio (OR) = 2.55, P = .005, and OR = 9.61, P = .001, respectively, and concentration difficulty (OR = 2.04, P = .033; OR = 6.19, P = .001, respectively). Conclusions This study is one of the first studies in Latin America to report an independent association of allergic rhinitis with loss of energy and concentration difficulty.

Our findings suggest that exposure to dogs, whether they be indoor or outdoor pets, is associated to a decreased prevalence in atopic dermatitis.

Background: It has recently been argued that asthma does not increase the risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. If so, the prevalence of asthma in subjects diagnosed with COVID-19 should be lower than in the general population. Objective: To determine the prevalence of asthma in Mexican children and adults with SARS-CoV-2 infection.Methods: A public database of the Epidemiological Surveillance System for Viral Respiratory Disease in Mexico was analyzed. Those who underwent the real-time reverse transcriptase-polymerase chain reaction-SARS-CoV-2 (rtRT-PCR-SARS-CoV-2) test from February 27 to June 21, 2020, were included. In addition to the prevalence of asthma, some factors associated with it were investigated. Results: Data from 417,366 subjects were analyzed. Asthma prevalence in children, adults, and global were 3.7%, 3.3%, and 3.3%, respectively. Although the asthma prevalence was lower in SARS-CoV-2 positive over negative patients, significant differences were only found in adults (2.8% vs. 3.7% respectively; odds ratio (OR) = 0.74; 95% confidence interval (CI): 0.71–0.77); but not in children (3.5% vs. 3.8%, respectively; OR = 0.91; 95%CI: 0.76–1.10). Multivariate analysis showed in younger than 18 years that girls and immunosuppression were factors associated with a decrease in the odds to develop asthma. In adults, asthma was positively associated with females, obesity, smoking, immunosuppression, chronic obstructive pulmonary disease, arterial hypertension, and cardiovascular disease.